Insight

Elvina Almuradova: Our New Paper on RAS Mutations in mCRC is Just Out in Medicina

Elvina Almuradova/LinkedIn

Jul 2, 2025, 09:34

Elvina Almuradova: Our New Paper on RAS Mutations in mCRC is Just Out in Medicina

Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology, shared a post on X about a paper she co-authored with colleagues published in Medicina:

“Our New paper on RAS mutations in mCRC is just out in Medicina! KRAS/NRAS, resistance, new G12C inhibitors and more.”

Title: RAS Mutations in Advanced Colorectal Cancer: Mechanisms, Clinical Implications, and Novel Therapeutic Approaches

Authors: Osman Sütcüoğlu, Hasan Çağrı Yıldırım, Elvina Almuradova, Damla Günenç, Şuayib Yalçın.

You can read the Full Article in Medicina.

Elvina Almuradova: Our New Paper on RAS Mutations in mCRC is Just Out in Medicina

More posts featuring Elvina Almuradova.

cancer colorectal cancer Damla Günenç Elvina Almuradova Hasan Cagri Yildirim mCRC Medicina OncoDaily Oncology Osman Sütcüoğlu RAS mutations Suayib Yalcin

ASCO 2026 Presidential Theme: Dr. Eric Small’s Vision to Translate Science Into Global Cancer Impact

MiNK Therapeutics Stock Surges on Breakthrough Testicular Cancer Remission and iNKT Cell Therapy Progress

Tabelecleucel (Ebvallo) FDA Update: Approval Delayed Despite Positive Phase 3 Data

New Paper Alert: Breakthrough iNKT Cell Therapy Achieves Complete Remission in Metastatic Germ Cell Tumor

"God Invented This" - Pat Soon-Shiong on Cancer Discovery